BCL2L1 and neoplasm: Aligned with the in vitro results, we found that nude mice bearing CAL33 tumors experienced less tumor growth and longer survival when treated with STAT3-MB + UTMC compared to the negative control groups, and this was associated with downregulation of target gene Bcl-xL and Cyc-D1 expression at the RNA transcript and protein levels.